Country Profile

Estonia

Estonia is a developing market for Indian pharmaceuticals — $1.75M in FY 2025–26. Surgical & Hospital Supplies accounts for 43% of shipments.

🇪🇪 $1.75M · 0.7× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$1.75M
Exports FY2025–26 DGCIS
0.7×
Growth FY2015→2026
43%
Surgical & Hospital Supplies Share
4
Product Categories Supplied
12
Years of Trade Data
Estonia is a developing market for Indian pharmaceuticals — $1.75M in FY 2025–26. Surgical & Hospital Supplies accounts for 43% of shipments.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Surgical & Hospital Supplies $749K (42.8%) Medicines $488K (27.9%) Medicine Ingredients $353K (20.2%) Traditional & Herbal $159K (9.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Estonia in the RBI overseas direct investment dataset (2011–2026).